CDKN1B and colorectal carcinoma: Compared with TCGA data, a significantly higher number of somatic mutations were observed in CDKN1B (p = 0.029), and significantly fewer mutations in APC and AMER1 were identified among the Chinese CRC patient cohort (p = 0.002 and p = 0.030, respectively).